EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentation
Jian Wang, Yuhan Qiu, Zoe Marti, Fengqi Li, Marcel Wacker, Pietro Oldrati, Lena Mühlenbruch, Linlin Jin, Hong Zhang, wen Xu, Tingting Li, Bernd Roschitzki, Wolfgang Faigle, Yingjun Liu, Julie T. Nguyen, Jar-How Lee, Veronika Haunerdinger, Mathias Hauri‐Hohl, Frank Momburg, Jens Bauer, Hans‐Georg Rammensee, Mireia Sospedra, Roberta Magliozzi, Richard Reynolds, Juliane S. Walz, Roland Martin
Abstract
Epstein-Barr virus (EBV) is involved in causing and probably also in perpetuating multiple sclerosis (MS). Among several mechanisms of how EBV may contribute are transcriptome alterations, including changes of antigen processing and preferential presentation of both viral and self-antigens. Here, we report that EBV reprograms the transcriptome and immunopeptidome presented on the MS-associated human leukocyte antigen (HLA)-DR15 molecules of infected B cells. Identical myelin basic protein (MBP) peptides were found to be presented on both EBV-infected B cells and MS brain tissue but not primary B cells and thymic tissue. Peripheral memory and cerebrospinal fluid (CSF)-derived CD4 + T cells of HLA-DR15 + MS patients responded to MBP peptides, MBP (78–90) and/or MBP (83–90) , and T cell clones raised with these peptides recognized all MBP peptides ending at amino acid MBP 90 in MS brain tissue. Our study provides a new mechanistic link for how the environmental and genetic risk factors, EBV infection and HLA-DR15 haplotype, may contribute jointly to MS.